J2H P1904
Alternative Names: J2H-P1904Latest Information Update: 30 Apr 2021
At a glance
- Originator J2H Biotech
- Class Antifibrotics; Hepatoprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Hepatic fibrosis
Most Recent Events
- 24 Mar 2021 Early research in Hepatic fibrosis in South Korea (unspecified route)